scholarly journals A North American Cohort of Anti‐SAE Dermatomyositis: Clinical Phenotype, Testing, and Review of Cases

2021 ◽  
Author(s):  
Jemima Albayda ◽  
Christopher Mecoli ◽  
Livia Casciola‐Rosen ◽  
Sonye K. Danoff ◽  
Cheng Ting Lin ◽  
...  
Keyword(s):  
North American ◽  
Clinical Phenotype ◽  
North American Cohort

scholarly journals Progress in Diagnosing Primary Ciliary Dyskinesia: The North American Perspective

Diagnostics ◽  
2021 ◽  
Vol 11 (7) ◽  
pp. 1278
Author(s):  
Michael Glenn O’Connor ◽  
Amjad Horani ◽  
Adam J. Shapiro
Keyword(s):  
Genetic Testing ◽  
North America ◽  
North American ◽  
Primary Ciliary Dyskinesia ◽  
Clinical Phenotype ◽  
The United States ◽  
Diagnostic Process ◽  
The North ◽  
Diagnostic Guideline ◽  
Ciliary Dyskinesia

Primary Ciliary Dyskinesia (PCD) is a rare, under-recognized disease that affects respiratory ciliary function, resulting in chronic oto-sino-pulmonary disease. The PCD clinical phenotype overlaps with other common respiratory conditions and no single diagnostic test detects all forms of PCD. In 2018, PCD experts collaborated with the American Thoracic Society (ATS) to create a clinical diagnostic guideline for patients across North America, specifically considering the local resources and limitations for PCD diagnosis in the United States and Canada. Nasal nitric oxide (nNO) testing is recommended for first-line testing in patients ≥5 years old with a compatible clinical phenotype; however, all low nNO values require confirmation with genetic testing or ciliary electron micrograph (EM) analysis. Furthermore, these guidelines recognize that not all North American patients have access to nNO testing and isolated genetic testing is appropriate in cases with strong clinical PCD phenotypes. For unresolved diagnostic cases, referral to a PCD Foundation accredited center is recommended. The purpose of this narrative review is to provide insight on the North American PCD diagnostic process, to enhance the understanding of and adherence to current guidelines, and to promote collaboration with diagnostic pathways used outside of North America.

Assessment of Osteoporosis and Fracture Risk in Mastocytosis within a North American Cohort

2021 ◽  
Author(s):  
Ayelet Makovoz ◽  
Jing Wang ◽  
Gloria Oshegbo ◽  
Young Hwan Park ◽  
Jonathan J. Lyons ◽  
...  
Keyword(s):  
Fracture Risk ◽  
North American ◽  
North American Cohort

Validation of WINROP for detecting retinopathy of prematurity in a North American cohort of preterm infants

2017 ◽  
Vol 21 (3) ◽  
pp. 229-233 ◽  
Author(s):  
Jennifer L. Jung ◽  
Brandie D. Wagner ◽  
Emily A. McCourt ◽  
Alan G. Palestine ◽  
Ashlee Cerda ◽  
...  
Keyword(s):  
Preterm Infants ◽  
Retinopathy Of Prematurity ◽  
North American ◽  
North American Cohort

Su1678 IMPACT OF RACE AND ETHNICITY ON OUTCOMES IN A MULTI-CENTER NORTH AMERICAN COHORT OF INPATIENTS WITH CIRRHOSIS

2020 ◽  
Vol 158 (6) ◽  
pp. S-612
Author(s):  
Jasmohan S. Bajaj ◽  
Jacqueline G. O'Leary ◽  
Puneeta Tandon ◽  
Florence Wong ◽  
Guadalupe Garcia-Tsao ◽  
...  
Keyword(s):  
North American ◽  
Race And Ethnicity ◽  
North American Cohort

Tu1109 The Global Incidence of Appendicitis: A Population-Based North American Cohort Study and Systematic Review

2015 ◽  
Vol 148 (4) ◽  
pp. S-789-S-790
Author(s):  
Samuel Quan ◽  
Mollie C. Ferris ◽  
Divine Tanyingoh ◽  
Belle Kaplan ◽  
Natalie A. Molodecky ◽  
...  
Keyword(s):  
Systematic Review ◽  
Cohort Study ◽  
North American ◽  
Population Based ◽  
North American Cohort

Risk Factors for Delta Hepatitis in a North American Cohort: Who Should Be Screened?

2020 ◽  
Vol 116 (1) ◽  
pp. 206-209
Author(s):  
Ben L. Da ◽  
Farial Rahman ◽  
Walter C. Lai ◽  
David E. Kleiner ◽  
Theo Heller ◽  
...  
Keyword(s):  
Risk Factors ◽  
North American ◽  
North American Cohort
Sign in / Sign up

Export Citation Format

Share Document